From Frontiers Forum:
How can research translate to R&D? Or a whole new business venture? In a panel session at Science Unlimited 2019, Holtzbrinck Publishing Group CEO Stefan von Holtzbrinck, Life Biosciences CEO Mehmood Khan, Logitech CEO Bracken Darrell and EPFL’s Henry Markram discussed innovation, R&D and successful technology transfer.
Stefan von Holtzbrinck, Holtzbrinck Publishing Group
Stefan von Holtzbrinck is CEO of the family-owned Holtzbrinck Publishing Group. He has 20 years’ experience in science communication, including 3 years as MD of Nature Publishing Group. The Holtzbrinck Publishing Group has majority holdings in Springer Nature (of which Stefan is Chairman of the Supervisory Board), Digital Science, DIE ZEIT and Macmillan, and investments in Holtzbrinck Ventures, Frontiers, AMBOSS, GSV AcceleraTE and Rethink Education fund. Stefan is a member of the Executive Committee of the Max Planck Society.
Mehmood Khan, Life Biosciences
Mehmood Khan is CEO and Board Member of Life Biosciences Inc, where he provides strategic direction and operational oversight. He was previously Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo and President of Global R&D at Takeda Pharmaceuticals. Before moving into industry, Mehmood had a distinguished medical career, including as a faculty member in endocrinology at the Mayo Clinic and Mayo Medical School where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit.
Bracken Darrell, Logitech
Bracken Darrell is President and CEO of Logitech, the largest Swiss consumer electronics company with CHF 3 billion in annual revenues. He is responsible for the company’s strategy for growth and profitability, for the vision for the brand as well as for the company’s operations. Logitech has been a top performer on both the Nasdaq and Swiss stock exchanges. The company value has risen by over 500 percent in the past seven years as the company has moved from PC peripherals to new categories and new brands.
Henry Markram, EPFL
Henry Markram has pioneered simulation neuroscience as a new path to understanding how the brain works. As Professor of Neuroscience at the Swiss Federal Institute of Technology in Lausanne (EPFL), he founded the Brain Mind Institute, the Blue Brain Project and the Human Brain Project, a €1 Billion European initiative to simulate the brain. His research has shifted from experimentally reverse engineering neocortical tissue to developing a software ecosystem and algorithms to convert biological data into detailed digital reconstructions of brain tissue.
Image Credit: Amanda Scott – Alias Studio Sydney
News This Week
For almost two decades, Stanford electrical engineering professor Krishna Shenoy and neuroscientists in his Neural Prosthetics Translational Laboratory have been working on implantable brain sensors that allow them to record and decipher the electrical [...]
In an incredible first, scientists have captured the world's first actual photo of quantum entanglement - a phenomenon so strange, physicist Albert Einstein famously described it as 'spooky action at a distance'. The image [...]
A team at Flinders University in South Australia has developed a new vaccine believed to be the first human drug in the world to be completely designed by artificial intelligence (AI). While drugs have [...]
Humans routinely send spacecraft into orbit to ensure services on the ground and to explore other planets. This extraordinary ability comes with a great responsibility: our space activity risks contaminating the space surrounding the [...]
Digital information technology has made information readily accessible to practically anyone, anytime and anywhere. This has had a profound effect in shaping all aspects of our society from industrial manufacturing, to distribution, to the [...]
The ways in which the communities of bacteria living within our bodies influence our overall well-being are becoming better understood all the time, and with that better understanding comes potential new ways to intervene [...]
Cancer breakthrough: Scientists discover a new Achilles’ Heel of tumors that causes them to self-destruct
Scientists have identified the Achilles' Heel of cancerous tumors, forcing the disease-spreading cells to over-stress and self-destruct. Experiments showed blocking a specific protein that fuels tumors kills them off. The technique worked on a [...]
Researchers at Oregon State University have developed an improved technique for using magnetic nanoclusters to kill hard-to-reach tumors. Magnetic nanoparticles - tiny pieces of matter as small as one-billionth of a meter - [...]
Plant leaves have a natural superpower — they’re designed with water repelling characteristics. Called a superhydrophobic surface, this trait allows leaves to cleanse themselves from dust particles. Inspired by such natural designs, a [...]
In a grainy black-and-white video shot at the Mayo Clinic in Minnesota, a patient sits in a hospital bed, his head wrapped in a bandage. He’s trying to recall 12 words for a memory [...]
From Frontiers Forum: How can research translate to R&D? Or a whole new business venture? In a panel session at Science Unlimited 2019, Holtzbrinck Publishing Group CEO Stefan von Holtzbrinck, Life Biosciences CEO [...]
More and more security holes are appearing in cryptocurrency and smart contract platforms, and some are fundamental to the way they were built. Early last month, the security team at Coinbase noticed something strange [...]
“The most crucial result of this work is the correlation between form and function in supercapacitor materials,” states first author Dina Ibrahim Abouelamaiem. She elaborates that “our research is driven by the need for [...]